01 8Smecta
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2020 Revenue in Millions : 98
2019 Revenue in Millions : 152
Growth (%) : -36
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2021 Revenue in Millions : 98
2020 Revenue in Millions : 98
Growth (%) : 10
Main Therapeutic Indication : Others
Currency : USD
2015 Revenue in Millions : 133
2014 Revenue in Millions : 127
Growth (%) : -5%
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2016 Revenue in Millions : 118
2015 Revenue in Millions : 122
Growth (%) : -3
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2017 Revenue in Millions : 143
2016 Revenue in Millions : 138
Growth (%) : 4
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 143
2017 Revenue in Millions : 140
Growth (%) : 2%
Main Therapeutic Indication : Others
Currency : USD
2014 Revenue in Millions : 2.70%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2019 Revenue in Millions : 137
2018 Revenue in Millions : 138
Growth (%) : -1
